Literature DB >> 21513292

Archazolid A-15-O-β-D-glucopyranoside and iso-archazolid B: potent V-ATPase inhibitory polyketides from the myxobacteria Cystobacter violaceus and Archangium gephyra.

Nicole Horstmann1, Sebastian Essig, Svenja Bockelmann, Helmut Wieczorek, Markus Huss, Florenz Sasse, Dirk Menche.   

Abstract

Two structurally novel analogues of the macrolides archazolids A and B, archazolid A-15-O-β-D-glucopyranoside (archazolid E, 5) and iso-archazolid B (archazolid F, 6), were isolated from the myxobacterium Cystobacter violaceus and Archangium gephyra, respectively. Macrolactone 5 represents the first 15-O-glycoside of the archazolids. iso-Archazolid B (6) incorporates a C-3 alkene and presents the first constitutional isomer reported for this natural product class. The structures of these polyketides were determined by spectroscopic analysis, in particular by HMBC, HMQC, and ROESY NMR investigations and by chemical degradation. iso-Archazolid B (6) demonstrated extremely high antiproliferative and V-ATPase inhibitory effects, with IC(50) values in the picomolar range, while only moderate activity was observed for glycoside 5. iso-Archazolid B presents the most potent archazolid known.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513292     DOI: 10.1021/np200036v

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  9 in total

1.  Revealing the macromolecular targets of complex natural products.

Authors:  Daniel Reker; Anna M Perna; Tiago Rodrigues; Petra Schneider; Michael Reutlinger; Bettina Mönch; Andreas Koeberle; Christina Lamers; Matthias Gabler; Heinrich Steinmetz; Rolf Müller; Manfred Schubert-Zsilavecz; Oliver Werz; Gisbert Schneider
Journal:  Nat Chem       Date:  2014-11-02       Impact factor: 24.427

Review 2.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

3.  Molecular and functional characterization of myxobacteria isolated from soil in India.

Authors:  Shiv Kumar; Arun Kumar Yadav; Priyanka Chambel; Ramandeep Kaur
Journal:  3 Biotech       Date:  2017-05-31       Impact factor: 2.406

4.  Synthesis of a C1-C23 fragment of the archazolids and evidence for V-ATPase but not COX inhibitory activity.

Authors:  Gregory W O'Neil; Alexander M Craig; John R Williams; Jeffrey C Young; P Clint Spiegel
Journal:  Synlett       Date:  2017-02-08       Impact factor: 2.454

5.  Synthesis of the C1-C17 fragment of the archazolids by complex cis-homodimer cross metathesis.

Authors:  Steven M Swick; Sara L Schaefer; Gregory W O'Neil
Journal:  Tetrahedron Lett       Date:  2015-06-24       Impact factor: 2.415

Review 6.  Total syntheses of the archazolids: an emerging class of novel anticancer drugs.

Authors:  Stephan Scheeff; Dirk Menche
Journal:  Beilstein J Org Chem       Date:  2017-06-07       Impact factor: 2.883

7.  Design, Synthesis and Biological Evaluation of Highly Potent Simplified Archazolids.

Authors:  Solenne Rivière; Christin Vielmuth; Christiane Ennenbach; Aliaa Abdelrahman; Carina Lemke; Michael Gütschow; Christa E Müller; Dirk Menche
Journal:  ChemMedChem       Date:  2020-06-10       Impact factor: 3.466

8.  Suzuki coupling-based synthesis of VATPase inhibitor archazolid natural product derived fragments.

Authors:  Cooper T Vincent; Evan T Long; Holly C Jones; Jeffrey C Young; P Clint Spiegel; Gregory W O'Neil
Journal:  RSC Adv       Date:  2019-10-10       Impact factor: 4.036

Review 9.  Design and Synthesis of Simplified Polyketide Analogs: New Modalities beyond the Rule of 5.

Authors:  Dirk Menche
Journal:  ChemMedChem       Date:  2021-05-05       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.